Reports for SANDOZ IRBESARTAN HCT
Brand name
SANDOZ IRBESARTAN HCT
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02337428 |
Ingredients
HYDROCHLOROTHIAZIDE IRBESARTAN |
Ingredient Strength
12.5 MG 150 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
SANDOZ IRBESARTAN HCT | 100 | Resolved | 2019-01-21 | 2020-07-20 | 73141 |
SANDOZ IRBESARTAN HCT | 500 | Resolved | 2019-01-21 | 2020-07-20 | 73144 |
SANDOZ IRBESARTAN HCT | 100FCT BO CA | Resolved | 2020-09-21 | 2020-10-27 | 124600 |
SANDOZ IRBESARTAN HCT | 500FCT BO CA | Resolved | 2020-09-21 | 2020-10-27 | 124606 |
SANDOZ IRBESARTAN HCT | 500 FCT BO | Resolved | 2020-11-27 | 2020-12-09 | 129102 |
SANDOZ IRBESARTAN HCT | 500FCT BO CA | Resolved | 2021-01-12 | 2021-03-08 | 131394 |
SANDOZ IRBESARTAN HCT | 100FCT | Resolved | 2023-03-13 | 2023-04-18 | 186967 |
SANDOZ IRBESARTAN HCT | 500FCT | Resolved | 2023-03-13 | 2023-05-03 | 186971 |
SANDOZ IRBESARTAN HCT | 100 FCT BO | Resolved | 2023-11-06 | 2023-12-12 | 209216 |
SANDOZ IRBESARTAN HCT | 500FCT | Resolved | 2024-01-03 | 2024-02-19 | 214777 |
Showing 1 to 10 of 10
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0